通过病理生理活动解码器揭示了Aβ和tau在阿尔茨海默病中的联合作用
Lazaro M Sanchez-Rodriguez1,2,3, Gleb Bezgin1,2,3,4, Felix Carbonell5
1Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
bioRxiv : the preprint server for biology
|July 28, 2023
概括
阿尔茨海默病 (AD) 模型将大脑活动与有毒蛋白质联系起来,揭示了粉样β和蛋白如何影响认知和神经元功能. 这种方法可以预测疾病的生物标志物,并澄清神经退行性机制,以获得更好的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 生物医学成像技术 生物医学成像技术
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 涉及复杂的神经元功能障碍和认知能力下降.
- 人类对AD病理生理学的证据有限,需要先进的非侵入性方法.
- 综合力学模型对于理解AD进展至关重要.
研究的目的:
- 为阿尔茨海默病研究开发个性化的大脑活动模型.
- 为了整合功能性MRI,粉样β (Aβ) PET和tau-PET数据.
- 阐明AD中毒蛋白沉积和神经元功能障碍之间的相互作用.
主要方法:
- 开发了脑活动的特定学科的计算模型.
- 整合了来自AD参与者的功能性MRI,Aβ-PET和tau-PET数据.
- 分析了蛋白质沉积,神经元刺激性和认知功能之间的关系.
主要成果:
- 确定了Aβ和tau对认知障碍的协同作用.
- 观察到与疾病进展相关的神经元刺激性增加.
- 证明神经元刺激性可以预测血AD生物标志物 (p-tau217,p-tau231,p-tau181,GFAP).
- 复制的标志性AD电生理变化 (甲基增强,α减小) 与Aβ和tau病理相关.
结论:
- 机械脑活动模型为神经退行过程提供了洞察力.
- 对特定主体的建模可以加速对AD的预防和治疗干预措施的开发.
- 由于神经成像的局限性,需要进一步的研究来澄清微质激活的作用.
相关概念视频
Alzheimer's Disease: Overview
524
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
524
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219


